Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology
- PMID: 10757248
- DOI: 10.1177/026988110001400101
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology
Abstract
A revision of the British Association for Psychopharmacology guidelines for treating depressive disorders with antidepressants was undertaken in order to specify the scope and target of the guidelines and to update the recommendations based explicitly on the available evidence. A consensus meeting, involving experts in depressive disorders and their treatment, reviewed key areas and considered the strength of evidence and clinical implications. The guidelines were drawn up after extensive feedback from participants and interested parties. A literature review is given which identifies the quality of evidence followed by recommendations, the strength of which are based on the level of evidence. The guidelines cover the nature and detection of depressive disorders, acute treatment with antidepressant drugs, choice of drug versus alternative treatment, practical issues in prescribing, management when initial treatment fails, continuation treatment, maintenance treatment to prevent recurrence and stopping treatment.
Similar articles
-
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.J Psychopharmacol. 2008 Jun;22(4):343-96. doi: 10.1177/0269881107088441. Epub 2008 Apr 15. J Psychopharmacol. 2008. PMID: 18413657
-
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.J Psychopharmacol. 2015 May;29(5):459-525. doi: 10.1177/0269881115581093. Epub 2015 May 12. J Psychopharmacol. 2015. PMID: 25969470
-
Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology.J Psychopharmacol. 2003 Jun;17(2):149-73; discussion 147. doi: 10.1177/0269881103017002003. J Psychopharmacol. 2003. PMID: 12870562
-
Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology.J Psychopharmacol. 2011 May;25(5):567-620. doi: 10.1177/0269881110391123. Epub 2011 Feb 3. J Psychopharmacol. 2011. PMID: 21292923
-
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.J Psychopharmacol. 2005 Nov;19(6):567-96. doi: 10.1177/0269881105059253. J Psychopharmacol. 2005. PMID: 16272179
Cited by
-
A qualitative study exploring how GPs decide to prescribe antidepressants.Br J Gen Pract. 2005 Oct;55(519):755-62. Br J Gen Pract. 2005. PMID: 16212850 Free PMC article.
-
Hampshire depression project: changes in the process of care and cost consequences.Br J Gen Pract. 2001 Nov;51(472):911-3. Br J Gen Pract. 2001. PMID: 11761205 Free PMC article. Clinical Trial.
-
Escitalopram: a pharmacoeconomic review of its use in depression.Pharmacoeconomics. 2003;21(16):1185-209. doi: 10.2165/00019053-200321160-00004. Pharmacoeconomics. 2003. PMID: 14594439 Review.
-
Selegiline transdermal system in major depressive disorder: profile report.CNS Drugs. 2007;21(6):521-4. doi: 10.2165/00023210-200721060-00007. CNS Drugs. 2007. PMID: 17521230 No abstract available.
-
The effect of cognitive behavior therapy-based psychotherapy applied in a forest environment on physiological changes and remission of major depressive disorder.Psychiatry Investig. 2009 Dec;6(4):245-54. doi: 10.4306/pi.2009.6.4.245. Epub 2009 Nov 17. Psychiatry Investig. 2009. PMID: 20140122 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
